Why the study?
Is vasopressin essential as a pressor hormone in the development of malignant renal hypertension and vascular lesions in rats?
Is vasopressin essential as a pressor hormone in the development of malignant renal hypertension and vascular lesions in rats?
Vasopressin is not essential as a pressor hormone in the development of malignant renal hypertension and associated vascular lesions.
Answers are grounded in this paper and cite their sources.
Vasopressin not required for malignant hypertension in rats; leaves open its role in human renovascular disease.
Vasopressin deficient homozygous Brattleboro rats develop malignant renal hypertension following complete aortic-ligature between the renal arteries. 2. This form of hypertension is associated with high plasma renin activity (PRA) and plasma angiotensin II (AII) levels and a high incidence of the specific vascular lesions of fibrinoid necrosis in both Brattleboro and Long-Evans rats. 3. The levels of PRA and AII in the malignant hypertensive Brattleboro rats were not different from those in Long-Evans rats with malignant hypertension. 4. No compensation by the renin-angiotensin system therefore could be demonstrated for the lack of vasopressin in malignant hypertensive Brattleboro rats. 5. Vasopressin does not appear to be essential as a pressor hormone in the development of malignant renal hypertension and fibrinoid can occur in the absence of vasopressin.
No takes yet. Share an insight, caveat, or question.
Woods et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: